Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2013 Feb 23;381(9867):626.
doi: 10.1016/S0140-6736(13)60343-8.

Resistance to second-line drugs in multidrug-resistant tuberculosis - Authors' reply

Comment

Resistance to second-line drugs in multidrug-resistant tuberculosis - Authors' reply

Tracy Dalton et al. Lancet. .
No abstract available

PubMed Disclaimer

Comment on

  • Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study.
    Dalton T, Cegielski P, Akksilp S, Asencios L, Campos Caoili J, Cho SN, Erokhin VV, Ershova J, Gler MT, Kazennyy BY, Kim HJ, Kliiman K, Kurbatova E, Kvasnovsky C, Leimane V, van der Walt M, Via LE, Volchenkov GV, Yagui MA, Kang H; Global PETTS Investigators; Akksilp R, Sitti W, Wattanaamornkiet W, Andreevskaya SN, Chernousova LN, Demikhova OV, Larionova EE, Smirnova TG, Vasilieva IA, Vorobyeva AV, Barry CE 3rd, Cai Y, Shamputa IC, Bayona J, Contreras C, Bonilla C, Jave O, Brand J, Lancaster J, Odendaal R, Chen MP, Diem L, Metchock B, Tan K, Taylor A, Wolfgang M, Cho E, Eum SY, Kwak HK, Lee J, Lee J, Min S, Degtyareva I, Nemtsova ES, Khorosheva T, Kyryanova EV, Egos G, Perez MT, Tupasi T, Hwang SH, Kim CK, Kim SY, Lee HJ, Kuksa L, Norvaisha I, Skenders G, Sture I, Kummik T, Kuznetsova T, Somova T, Levina K, Pariona G, Yale G, Suarez C, Valencia E, Viiklepp P. Dalton T, et al. Lancet. 2012 Oct 20;380(9851):1406-17. doi: 10.1016/S0140-6736(12)60734-X. Epub 2012 Aug 30. Lancet. 2012. PMID: 22938757 Free PMC article.
  • Resistance to second-line drugs in multidrug-resistant tuberculosis.
    Udwadia Z. Udwadia Z. Lancet. 2013 Feb 23;381(9867):625-6. doi: 10.1016/S0140-6736(13)60342-6. Lancet. 2013. PMID: 23439096 No abstract available.
  • Resistance to second-line drugs in multidrug-resistant tuberculosis.
    Nyang'wa BT, Brigden G, du Cros P, Shanks L. Nyang'wa BT, et al. Lancet. 2013 Feb 23;381(9867):625. doi: 10.1016/S0140-6736(13)60341-4. Lancet. 2013. PMID: 23439097 No abstract available.

Substances

LinkOut - more resources